Zentek Q1 2027 Earnings Report

Zentek EPS Results

• Actual EPS: -$0.01
• Consensus EPS: -$0.02
• Beat/Miss: Beat by +$0.01
• One Year Ago EPS: N/A

Zentek Revenue Results

• Actual Revenue: N/A
• Expected Revenue: $0.24 million
• Beat/Miss: N/A
• YoY Revenue Growth: N/A

Zentek Announcement Details

• Quarter: Q1 2027
• Date: 8/14/2026
• Time: Before Market Opens
• Conference Call Date: N/A
• Conference Call Time: N/A

Zentek (NASDAQ:ZTEK) (NASDAQ: ZTEK) is a Canadian nanotechnology company that develops and commercializes advanced materials and technology solutions. Its work is centered on graphene and other nanomaterials, with applications in healthcare, air filtration, surface protection and industrial products.

The company’s product portfolio has included ZENGuard, an antimicrobial coating designed for use in protective equipment and air-filtration systems. Zentek has also developed graphene-enhanced filtration products and technologies intended to improve the capture and inactivation of airborne contaminants. In addition, the company is pursuing applications involving ice-phobic and corrosion-resistant coatings, as well as biomedical technologies such as aptamer-based detection platforms.

Zentek is headquartered in Canada and has historically focused on developing technologies for domestic and international markets through commercialization partners, licensing arrangements and product sales. The company was previously known as ZEN Graphene Solutions and adopted the Zentek name as it expanded beyond its original graphene-resource focus. Its activities have included the evaluation and development of the Albany Graphite deposit in Ontario, although its current business strategy emphasizes technology commercialization.

The company has been led by Greg Fenton as chief executive officer, alongside a management and technical team focused on nanomaterials, product development and commercialization.